Cargando…
Combined growth hormone and insulin-like growth factor-1 rescues growth retardation in glucocorticoid-treated mdxmice but does not prevent osteopenia
Short stature and osteoporosis are common in Duchenne muscular dystrophy (DMD) and its pathophysiology may include an abnormality of the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis, which is further exacerbated by long-term glucocorticoid (GC) treatment. Hence, an agent that has anab...
Autores principales: | Wood, Claire L, van ‘t Hof, Rob, Dillon, Scott, Straub, Volker, Wong, Sze C, Ahmed, S Faisal, Farquharson, Colin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010817/ https://www.ncbi.nlm.nih.gov/pubmed/35191394 http://dx.doi.org/10.1530/JOE-21-0388 |
Ejemplares similares
-
SAT-530 Establishment of a Glucocorticoid (GC) Regimen to Induce Both Growth Retardation and Osteoporosis in C57BL/10 Muscular Dystrophy Mouse Models
por: Wood, Claire, et al.
Publicado: (2019) -
A comparison of the bone and growth phenotype of mdx, mdx:Cmah(−/−) and mdx:Utrn(+/−) murine models with the C57BL/10 wild-type mouse
por: Wood, Claire L., et al.
Publicado: (2020) -
Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy
por: Nikishina, I, et al.
Publicado: (2008) -
Brachydactyly mental retardation syndrome with growth hormone deficiency
por: Arefzadeh, Alireza, et al.
Publicado: (2018) -
Retarded Growth
Publicado: (1883)